Ondřej Novák

Date of appointment: General Meeting of 10 June 2024
End of term of office: General Meeting convene to approve the financial statements for the year ending 31 December 2026

Graduated from the Charles University in Prague, Mr. Ondřej Novák began his career in 2003 as a lawyer in Komerční banka, an affiliate of the Société Générale’s group in the Czech Republic. In 2004, Mr. Ondřej Novák founded Pharmservice, a company specialized in the organisation of clinical research and pharmaceutical consulting in the Czech Republic and Slovakia.

Between 2007 and 2010, Mr. Ondřej Novák managed Novatin, a generic pharmaceutical company specialized in import and sale of medical devices, which he co-founded.

In 2010, Mr. Ondřej Novák joined the Law office Panýr as healthcare legal expert specialized, in particular, in the areas of the pharmaceutical industry and in public health insurance and relations between insurance companies and healthcare providers.

Between 2011 and 2018 Mr. Ondřej Novák was also a member of the Working Group of the Diabetes Association of the Czech Republic as a legal expert.

In 2023, Mr. Ondřej Novák has co-founded Bioinvestimed, an investment company focused on biomedical and pharmaceutical projects.

Mr. Ondřej Novák is also:

• Vice-Chairman of the Board of Trustees and Chief Executive Officer of the Holecek Family Foundation; 
• Member of the Supervisory Board of CasInvent Pharma;
• Member of the Board of Directors of Bioinvestimed;
• Member of the Board of Directors of Leima Valeurs.